Skip to main content
Year archive

Qiagen N.V. — 2025 filings

All 44 regulatory filings released by Qiagen N.V. (QIA) in 2025, sourced directly from the official regulator.

44 Filings
2025 Period
2025 filings (44)
Filing Released Lang
6-K
Foreign Filer Report
2025-12-19 English
Major Shareholding Notification 2025
Major Shareholding Notification
2025-11-12 English
Q3 statement / Q3 financial report 2025
Interim / Quarterly Report 9M 2025
2025-11-06 English
6-K
Foreign Filer Report
2025-11-05 English
6-K
Foreign Filer Report
2025-11-05 English
Ad hoc Announcement according to Art. 17 Market Abuse Regulation
Transaction in Own Shares
2025-11-05 English
Ad hoc Announcement according to Art. 17 Market Abuse Regulation
Earnings Release Q3 2025
2025-11-05 English
QIAGEN N.V.: QIAGEN announces CEO transition plan
Board/Management Information
2025-11-04 English
Qiagen N.V., Halfjaarlijkse financiële verslaggeving
Interim / Quarterly Report H1 2025
2025-09-30 English
6-K
Foreign Filer Report
2025-08-29 English
Ad-hoc announcement pursuant to Art. 17 MAR - QIAGEN N.V. launches non-US offering of net share settled convertible bonds
Capital/Financing Update
2025-08-28 English
QIAGEN N.V.: QIAGEN N.V. launches non-US offering of net share settled convertible bonds
Capital/Financing Update
2025-08-28 English
Half-yearly financial report 2025
Interim / Quarterly Report H1 2025
2025-08-22 English
6-K
Foreign Filer Report
2025-08-21 English
Regulatory Filings 2025
Regulatory Filings
2025-08-15 English
Regulatory Filings 2025
Regulatory Filings
2025-08-15 English
Regulatory Filings 2025
Regulatory Filings
2025-08-14 English
Regulatory Filings 2025
Regulatory Filings
2025-08-13 English
Major Shareholding Notification 2025
Major Shareholding Notification
2025-08-12 English
6-K
Foreign Filer Report
2025-08-06 English
QIAGEN exceeds outlook for Q2 2025 with solid growth and improved profitability
Earnings Release Q2 2025
2025-08-06 English
6-K
Foreign Filer Report
2025-06-27 English
SD
Regulatory Filings
2025-05-30 English
Major Shareholding Notification 2025
Major Shareholding Notification
2025-05-14 English
Q1 statement / Q1 financial report 2025
Interim / Quarterly Report Q1 2025
2025-05-13 English
6-K
Foreign Filer Report
2025-05-12 English
6-K
Foreign Filer Report
2025-05-08 English
QIAGEN announces plans for transition in leadership of Supervisory Board
Board/Management Information
2025-05-08 English
QIAGEN delivers solid Q1 2025 results exceeding outlook; will seek shareholder approval to initiate a dividend and new $500 mn repurchase
Earnings Release Q1 2025
2025-05-08 English
QIAGEN to propose initiation of annual cash dividend for shareholder approval at Annual General Meeting
Notice of Dividend Amount
2025-05-07 English
QIAGEN N.V.: QIAGEN to propose initiation of annual cash dividend for shareholder approval at Annual General Meeting
Notice of Dividend Amount
2025-05-07 English
Qiagen N.V., Jaarlijkse financiële verslaggeving
Annual Report FY 2024
2025-04-28 English
6-K
Foreign Filer Report
2025-04-08 English
QIAGEN N.V.: QIAGEN announces strong preliminary Q1 2025 results and updates full-year 2025 adjusted earnings per share outlook
Earnings Release Q1 2025
2025-04-06 English
Annual financial report 2024
Annual Report FY 2024
2025-03-31 English
IRANNOTICE
Regulatory Filings
2025-03-28 English
20-F
Annual Report FY 2024
2025-03-28 English
6-K
Foreign Filer Report
2025-02-06 English
Major Shareholding Notification 2025
Major Shareholding Notification
2025-02-06 English
QIAGEN delivers solid Q4 2024 growth ahead of outlook
Earnings Release Q4 2024
2025-02-06 English
6-K
Foreign Filer Report
2025-01-16 English
QIAGEN N.V.: QIAGEN to return approximately $300 million to shareholders through a synthetic share repurchase
Transaction in Own Shares
2025-01-13 English
6-K
Foreign Filer Report
2025-01-13 English
QIAGEN N.V.: QIAGEN to return approximately $300 million to shareholders through a synthetic share repurchase
Share Issue/Capital Change
2025-01-12 English